Abstract 4504: Synergistic antitumor activity of the MTA-cooperative PRMT5 inhibitor ABSK131 in combination with multiple therapeutic agents in diverse cancer models.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Abbisko Therapeutics Co., Ltd. (China)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148648390
Cites:
Cited by:
Related to: